Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
rp5063 dopamine d2 receptor NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Unipolar Depression[MeSHID:D003866]
Parkinson Disease[MeSHID:D010300]
Bipolar Disorder[MeSHID:D001714]
Attention deficit hyperactivity disorder[MeSHID:D001289]
Major Depressive Disorder[MeSHID:D003865]
Schizophrenia[MeSHID:D012559]		 NA phase 2 unknown
rp5063 dopamine d3 receptor NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Unipolar Depression[MeSHID:D003866]
Parkinson Disease[MeSHID:D010300]
Bipolar Disorder[MeSHID:D001714]
Attention deficit hyperactivity disorder[MeSHID:D001289]
Major Depressive Disorder[MeSHID:D003865]
Schizophrenia[MeSHID:D012559]		 NA phase 2 unknown
rp5063 dopamine d4 receptor NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Unipolar Depression[MeSHID:D003866]
Parkinson Disease[MeSHID:D010300]
Bipolar Disorder[MeSHID:D001714]
Attention deficit hyperactivity disorder[MeSHID:D001289]
Major Depressive Disorder[MeSHID:D003865]
Schizophrenia[MeSHID:D012559]		 NA phase 2 unknown
rp5063 histamine h1 receptor NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Unipolar Depression[MeSHID:D003866]
Parkinson Disease[MeSHID:D010300]
Bipolar Disorder[MeSHID:D001714]
Attention deficit hyperactivity disorder[MeSHID:D001289]
Major Depressive Disorder[MeSHID:D003865]
Schizophrenia[MeSHID:D012559]		 NA phase 2 unknown
rp5063 5-ht 1a receptor NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Unipolar Depression[MeSHID:D003866]
Parkinson Disease[MeSHID:D010300]
Bipolar Disorder[MeSHID:D001714]
Attention deficit hyperactivity disorder[MeSHID:D001289]
Major Depressive Disorder[MeSHID:D003865]
Schizophrenia[MeSHID:D012559]		 NA phase 2 unknown
rp5063 5-ht 2a receptor NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Unipolar Depression[MeSHID:D003866]
Parkinson Disease[MeSHID:D010300]
Bipolar Disorder[MeSHID:D001714]
Attention deficit hyperactivity disorder[MeSHID:D001289]
Major Depressive Disorder[MeSHID:D003865]
Schizophrenia[MeSHID:D012559]		 NA phase 2 unknown
rp5063 5-ht 7 receptor NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Unipolar Depression[MeSHID:D003866]
Parkinson Disease[MeSHID:D010300]
Bipolar Disorder[MeSHID:D001714]
Attention deficit hyperactivity disorder[MeSHID:D001289]
Major Depressive Disorder[MeSHID:D003865]
Schizophrenia[MeSHID:D012559]		 NA phase 2 unknown
click here to return to the previous page